Document is current
Any future updates will be listed below
-
Authors
Madissoon, Elo
Oliver, Amanda J. https://orcid.org/0000-0003-1690-9027
Kleshchevnikov, Vitalii
Wilbrey-Clark, Anna
Polanski, Krzysztof https://orcid.org/0000-0002-2586-9576
Richoz, Nathan
Ribeiro Orsi, Ana https://orcid.org/0000-0002-4939-1423
Mamanova, Lira https://orcid.org/0000-0003-1463-8622
Bolt, Liam
Elmentaite, Rasa https://orcid.org/0000-0001-7366-5466
Pett, J. Patrick https://orcid.org/0000-0002-5249-444X
Huang, Ni
Xu, Chuan
He, Peng https://orcid.org/0000-0002-2457-3554
Dabrowska, Monika
Pritchard, Sophie
Tuck, Liz https://orcid.org/0000-0002-1837-7549
Prigmore, Elena https://orcid.org/0000-0001-8870-0316
Perera, Shani
Knights, Andrew
Oszlanczi, Agnes
Hunter, Adam
Vieira, Sara F. https://orcid.org/0000-0002-1021-3021
Patel, Minal
Lindeboom, Rik G. H. https://orcid.org/0000-0002-3660-504X
Campos, Lia S.
Matsuo, Kazuhiko
Nakayama, Takashi https://orcid.org/0000-0002-8493-899X
Yoshida, Masahiro https://orcid.org/0000-0002-3521-5322
Worlock, Kaylee B. https://orcid.org/0000-0002-5656-7634
Nikolić, Marko Z. https://orcid.org/0000-0001-6304-6848
Georgakopoulos, Nikitas https://orcid.org/0000-0002-1879-6583
Mahbubani, Krishnaa T. https://orcid.org/0000-0002-1327-2334
Saeb-Parsy, Kourosh https://orcid.org/0000-0002-0633-3696
Bayraktar, Omer Ali https://orcid.org/0000-0001-6055-277X
Clatworthy, Menna R.
Stegle, Oliver
Kumasaka, Natsuhiko https://orcid.org/0000-0002-3557-0375
Teichmann, Sarah A. https://orcid.org/0000-0002-6294-6366
Meyer, Kerstin B. https://orcid.org/0000-0001-5906-1498
- License Information
-
More Information
Article History
Received: 26 July 2022
Accepted: 25 October 2022
First Online: 21 December 2022
Change Date: 29 September 2025
Change Type: Update
Change Details: In the version of the article initially published, the funding acknowledgment for Amanda J. Oliver was incomplete and has now been amended to “A.J.O. was supported by the European Respiratory Society and the European Union’s H2020 research and innovation program under Marie Sklodowska-Curie grant agreement number 847462” in the HTML and PDF versions of the article.
Competing interests
: In the past three years, SAT has received remuneration for consulting and Scientific Advisory Board Membership from Genentech, Roche, Biogen, GlaxoSmithKline, Foresite Labs and Qiagen. SAT is a cofounder, board member and holds equity in Transition Bio. OS is a paid member of the Scientific Advisory Board of Insitro. The remaining authors declare no competing interests.
